Developing and validating model systems for immuno-oncology.

Claire E McCarthy
Nastaran Zahir
Mariam Eljanne
Elad Sharon
Emile E Voest
Karolina Palucka, The Jackson Laboratory


Owing to clinical success of immune-checkpoint blockade, immunotherapy is becoming a cornerstone of modern oncology, and immuno-oncology is at the forefront of basic cancer research. This commentary outlines future opportunities for immuno-oncology modeling.